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ndocarditis related to a transvenously implanted cardiac
resynchronization therapy (CRT) system is a rare but se-
rious therapeutic challenge, particularly in those patients
in whom interruption of biventricular stimulation induces
dramatic deterioration of their hemodynamic status.
Clinical Summary
We report the case of a 57-year-old man with a CRT system im-
planted transvenously in 2003 owing to dilative cardiomyopathy,
in whom infective endocarditits with blood cultures positive for
methicillin-resistant Staphylococcus epidermidis was diagnosed.
The preoperative transthoracic echocardiogram revealed abnormal,
moving echoes in the right atrium, impaired left ventricular ejection
fraction of 20%, moderate mitral regurgitation, and severe tricuspid
regurgitation. Transesophageal echocardiography confirmed the
presence of two large vegetations (.1 cm in diameter) attached to
the pacing leads within the right atrium (Figure 1). A temporary in-
terruption of biventricular stimulation during preoperative echocar-
diography induced a deterioration of global systolic function,
appearance of asynchrony, increase in mitral regurgitation, and after
15 minutes, signs of dyspnea and orthopnea. Consequently, the pa-
tient was qualified for a combined procedure of surgical removal of
the infected CRT system with concomitant implantation of a new
system with the use of epicardial leads.
The intervention was carried out with a median sternotomy ap-
proach, cardiopulmonary bypass, and cardioplegic arrest. After
opening of the right atrium, the left ventricular lead proved to be
firmly connected to the atrial wall by a tissue sleeve (Figure 2). Its
mobilization was possible only after careful surgical separation.
Subsequently, the distal ends of all three leads were completely re-
moved from the heart and cut off at the level of the superior vena
cava. The examination of the tricuspid valve did not reveal any path-
ologic condition necessitating surgical intervention. Bipolar epicar-
dial leads (CapSure Epi 4968; Medtronic, Inc, Minneapolis, Minn)
were implanted on the right atrium, right ventricle, and the lateral
wall of the left ventricle within the most delayed segment according
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crossclamp, in the reperfusion period the pacing and sensing param-
eters were verified and subsequently the leads were connected to the
biventricular pacemaker (Insync III; Medtronic) located in the ab-
dominal wall. The biventricular stimulation was activated. After
weaning from cardiopulmonary bypass, the sternotomy was closed
routinely, and subsequently the old pacemaker was removed com-
pletely with the proximal ends of the old leads. The postoperative
course was uneventful. The samples cultures confirmed the S. epi-
dermidis etiology of the infection. After 30 days of antimicrobial
treatment, the blood cultures were sterile and the patient’s clinical
status improved. In the predischarge echocardiogram, an improve-
ment in CRT effect compared with preoperative status was con-
firmed with a left ventricular ejection fraction of 35% and
a reduction in mitral and tricuspid regurgitation. The patient was dis-
charged in very good general condition and leads a normal life.
Discussion
In recent years CRT has been proved to be an effective treatment
option for patients with congestive heart failure and systolic dyssyn-
chrony.1 However, the increasing implementation of CRT in clinical
practice will result in a growing number of patients with endocardi-
tis related to CRT pacing leads. It has been demonstrated that the
only efficient treatment method of endocarditis on pacemaker leads
is the removal of the entire pacing system.2,3 On the other hand, in
some patients with advanced heart failure, the continuity of CRT
therapy with its acute beneficial impact on systolic synchrony, dia-
stolic filling time, and mitral regurgitation is crucial for maintaining
hemodynamic stability.
Figure 1. Transesophageal echocardiogram showing two vegeta-
tions greater than 10 mm in diameter in the right atrium.tember 2008
Brief CommunicationsIn this setting, the surgical extraction of the CRT system with
concomitant implantation of the new system with the use of epicar-
dial leads may be a promising solution.
Moreover, the excellent exposition of the heart helps to overcome
the limitations associated with coronary sinus anatomy, inasmuch as
the left ventricular lead can be easily placed at the optimal site, which
is of greatest importance for maximizing the benefit from CRT.4
We used bipolar nonpenetrating epicardial leads. The steroid-
eluting tips prevent local fibrosis at the implantation site and ensure
very good pacing and sensing parameters at long-term follow-up.4
Figure 2. CRT system extracted from the patient.The Journal of ThorSome authors advocate transvenous pacemaker lead removal
regardless the size of vegetations.5 However, an extensive body of
evidence supports the strategy of surgical extraction in case of veg-
etations exceeding 10 mm in diameter to prevent embolic complica-
tions.2 Moreover, in this case an attempt at transvenous removal
could be risky considering the solid tissue sleeve connecting the
left ventricular lead to the atrial wall (Figure 2).
In conclusion, we propose surgical extraction of the transve-
nously implanted CRT system with concomitant implantation of
a new epicardial system as an effective treatment method of infec-
tive endocarditis, without the necessity of CRT interruption.
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